Further Support for CRC Screening to Start at Age 45: Meta-AnalysisApril 12, 2024OncologyColon and Rectal
Repeat MCED Testing May ID Early-Stage and Unscreened CancersApril 10, 2024Breast CancerGenitourinary CancerLung CancerMelanomaOncologyProstate Cancer
Less Than 50% of Accelerated Approvals Show Clinical BenefitApril 9, 2024Breast CancerGenitourinary CancerMelanomaMixed TopicsAMLMultiple MyelomaOncology
New Quality Measure Improves Follow-Up for CRC ScreeningApril 9, 2024OncologyBusiness of MedicineColon and Rectal
EBER-Negative, Double-Hit High-Grade B-Cell Lymphoma Responding to Methotrexate DiscontinuationApril 8, 2024OncologyProstate Cancer
Virtual Reality Brings Relief to Hospitalized Patients With CancerApril 8, 2024OncologyPainBreast CancerGenitourinary CancerLung CancerMelanomaAML
Prostate Cancer Tsunami Coming, Experts CautionApril 5, 2024Genitourinary CancerDiversity in MedicineOncologyBusiness of MedicineProstate Cancer
Should Opioids Be Used for Chronic Cancer Pain?April 5, 2024Breast CancerFast Facts FridayLung CancerMelanomaMixed TopicsAMLMyelodysplastic Syndrome
A Banned Chemical That Is Still Causing CancerApril 3, 2024Breast CancerGenitourinary CancerLung CancerMelanomaMixed TopicsOncologyBusiness of Medicine
Lung Cancer Vaccine Gets Injection of Funding for Research and DevelopmentApril 2, 2024Lung CancerOncology
Active Surveillance for Cancer Doesn’t Increase Malpractice RiskApril 1, 2024Genitourinary CancerBreast CancerLung CancerMelanomaAMLBusiness of MedicineMixed Topics
